Health and Healthcare
5864 Articles
We are seeing many key movers in the BioHealth space today. Biotech stocks and drug stocks are often more volatile…
Virtually nothing has gone right at Boston Scientific (BSX) since it bought rival Guidant in a bidding war with Johnson & Johnson (JNJ)…
This week we have several issues to watch. Earnings season is mostly done but there are still many on deck…
Pfizer (PFE) and other big pharma companies have been under assault for several years as some of their most profitable drugs…
Average: “an estimation of or approximation to an arithmetic mean”–Webster The smartest move that J. Raymond Elliot made in his…
Biophama companies are horrible investments at least 90% of the time because they are gambles on the IQs of small groups of…
Biotech firm XenoPort (XNPT) will lay-off half of its employees. The company lists 219 full-time workers. On February 17, the FDA rejected…
All the US government has to do to pay for the current healthcare reform proposal is eliminate foodborne illnesses like botulism, salmonella,…
Anthera Pharmaceuticals, Inc. (NASDAQ: ANTH) is a very unusual Monday IPO. The fact that it is being viewed as a…
There are twelve major pharmaceutical firms that dominate this industry worldwide. Their combined market value is over $1 trillion with total…
The Administration’s ambitious healthcare plan will not make it through Congress. A scaled down version might. The initial broad program had the…
The FDA continued is blundering and fumbling as the protector of the American public from big pharma. On the “drugs…
Humana (NYSE:HUM) will cut 2,500 jobs in one of its business units but add back enough workers in other areas so…
Boston Scientific (NYSE:BSX), the worst run of the large medical device and pharma firms based in the US, announced an operating…
This past week was filled with many surprises and earnings are still coming on strong. We wanted to look at some…
Our top personal finance-related articles today. Your wallet will thank you later.